The society’s current clinical guidelines for gender-affirming care outlines terminology, when hormone treatment should be used and how the treatment should be managed. The guidance has not been updated since 2017, and the organization said the review process will take three years.
The decision to review the guidelines was not spurred by politics, according to the Endocrine Society. A committee, composed of the organization’s members and other gender-affirming care experts, will examine the latest research and developments to create best practices to care for the nation’s 1.6 million transgender adults and children.
Revisions last happened after an eight-year gap, between 2009 and 2017, according to CNN.
Every major medical association in the U.S., including the American Medical Association and the American Psychiatric Association, agrees gender-affirming care is clinically appropriate, the report said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
